No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
HLN Haleon
- 8.920
- +0.010+0.11%
Close Jul 22 16:00 ET
- 8.980
- +0.060+0.67%
Post 18:18 ET
40.73BMarket Cap29.44P/E (TTM)
8.990High8.890Low2.77MVolume8.980Open8.910Pre Close24.68MTurnover0.08%Turnover Ratio30.55P/E (Static)4.57BShares8.99552wk High1.90P/B29.68BFloat Cap7.60152wk Low0.15Dividend TTM3.33BShs Float8.995Historical High1.70%Div YieldTTM1.12%Amplitude5.451Historical Low8.917Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
U.S. Pediatric Supplements Market Insights 2024-2029 Featuring Key Vendors - Abbott, Amway, Haleon, Bayer, Reckitt Benckiser, Nestle, Sanofi-aventis, Unilever, THG, H&H - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. Pediatric Supplements Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. pediatric supplements market is
Morgan Stanley Maintains Haleon(HLN.US) With Buy Rating, Raises Target Price to $9.45
Morgan Stanley analyst Rashad Kawan maintains $Haleon(HLN.US)$ with a buy rating, and adjusts the target price from $9 to $9.45.According to TipRanks data, the analyst has a success rate of 49.0%
Haleon PLC (HLN) Gets a Buy From Barclays
Express News | Haleon PLC : Morgan Stanley Raises Target Price to $9.45 From $9.3
Small, Mid-size Biotechs Could See M&A Action in H2 - PwC
United Kingdom Oral Care Market Forecast and Opportunities to 2029, Featuring Procter & Gamble, GlaxoSmithKline, Colgate, Unilever, Spotlight Oral Care, Haleon and Oral Care Innovations
Comments
$Haleon(HLN.US$ COVID on the rise again...Haleon's Panadol will b flying off the shelves again as it offers the best flu symptoms relief.
$SIA(C6L.SG$ $HKEX(00388.HK$ $DBS Group Holdings(D05.SG$ $OCBC Bank(O39.SG$ $SATS(S58.SG$ $Olam Group(VC2.SG$ $CapitaLandInvest(9CI.SG$ $CapLand Ascott Trust(HMN.SG$ $Sheng Siong(OV8.SG$ $Top Glove(BVA.SG$ $Singtel 10(Z77.SG$ $ParkwayLife Reit(C2PU.SG$ $Novo-Nordisk A/S(NVO.US$ $Grab Holdings(GRAB.US$
$SIA(C6L.SG$ $HKEX(00388.HK$ $DBS Group Holdings(D05.SG$ $OCBC Bank(O39.SG$ $SATS(S58.SG$ $Olam Group(VC2.SG$ $CapitaLandInvest(9CI.SG$ $CapLand Ascott Trust(HMN.SG$ $Sheng Siong(OV8.SG$ $Top Glove(BVA.SG$ $Singtel 10(Z77.SG$ $ParkwayLife Reit(C2PU.SG$ $Novo-Nordisk A/S(NVO.US$ $Grab Holdings(GRAB.US$
1
3
$Haleon(HLN.US$ Can someone please let me know why this is way cheaper than the Haleon PLC listed on LSE?
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Encompass Health(EHC.US$ - up 8.0%
2. $KT Corp(KT.US$ - up 1.9%
3. $Haleon(HLN.US$ - up 1.7%
4. $ServiceNow(NOW.US$ - up 1.3%
5. $Elbit Systems(ESLT.US$ - up 0.8%
6. $Check Point Software(CHKP.US$ - up 0.4%
7. $GlaxoSmithKline(GSK.US$ - up 0.4%
8. $Diageo(DEO.US$ - u...
Gap Ups
1. $Encompass Health(EHC.US$ - up 8.0%
2. $KT Corp(KT.US$ - up 1.9%
3. $Haleon(HLN.US$ - up 1.7%
4. $ServiceNow(NOW.US$ - up 1.3%
5. $Elbit Systems(ESLT.US$ - up 0.8%
6. $Check Point Software(CHKP.US$ - up 0.4%
7. $GlaxoSmithKline(GSK.US$ - up 0.4%
8. $Diageo(DEO.US$ - u...
+11
9
1
$Haleon(HLN.US$ buy sell or hold? Exceeded my expectations too soon. Perplexed.
$Sheng Siong(OV8.SG$ $Food Empire(F03.SG$ $Olam Group(VC2.SG$ $Wilmar Intl(F34.SG$ $ComfortDelGro(C52.SG$ $GlaxoSmithKline(GSK.US$ $UBS Group(UBS.US$ $Unilever(UL.US$
$Sheng Siong(OV8.SG$ $Food Empire(F03.SG$ $Olam Group(VC2.SG$ $Wilmar Intl(F34.SG$ $ComfortDelGro(C52.SG$ $GlaxoSmithKline(GSK.US$ $UBS Group(UBS.US$ $Unilever(UL.US$
3
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg